Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Sanofi Plans to Cut the Price of Insulin

The New York Times – Business:

The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Diabetes, Drugs (Pharmaceuticals), Eli Lilly and Company, Health Insurance and Managed Care, Insulin, Novo Nordisk A/S, Prices (Fares, Fees and Rates), Sanofi SA
←Finding a Buyer for TikTok May Not Be So Easy
Lewis Spratlan, Who Took Winding Route to Music Pulitzer, Dies at 82→

More posts

  • Oude Waag Shanghai Spring 2027

  • Innovative Rights Deal Paves Way For “Immediate Capital Return” To Broadway Investors In Alicia Keys Musical ‘Hell’s Kitchen’

  • El-Sayed labels AI ‘existential threat’

  • Jeffries: Nothing to merit ‘extraordinary raid’ on Omar home

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube